
AOP Health
VPOIS
Public Scientific Service (hereinafter referred to as the “VPOIS”) concerned with medicinal products in accordance with § 33, Paragraph 3g), Section 1 of Act No. 378/2007 Coll., on Pharmaceuticals and on Amendments to Some Related Acts (Act on Pharmaceuticals)
Product Overview
Název přípravku | SmPC | PIL | dodáván do ČR |
ADASUVE | SmPC Adasuve | PIL Adasuve | NE |
ADEPEND 50 MG POTAHOVANÉ TABLETY | SmPC Adepend | PIL Adepend | NE |
AMBRISENTAN AOP | SmPC Ambrisentan AOP | PIL Ambrisentan AOP | NE |
ANAGRELID AOP | SmPC Anagrelid AOP | PIL Anagrelid AOP | NE |
BESREMI | SmPC Besremi | PIL Besremi | ANO |
EMBESIN | SmPC Embesin | PIL Embesin | ANO |
ESMOCARD | SmPC Esmocard | PIL Esmocard | ANO |
ESMOCARD LYO | SmPC Esmocard LYO | PIL Esmocard LYO | ANO |
NALBUPHIN ORPHA | SmPC Nalbuphin Orpha | PIL Nalbuphin Orpha | ANO |
NALTREXONE AOP 50 MG | SmPC Naltrexone AOP | PIL Naltrexone AOP | NE |
OCALIVA | SmPC Ocaliva | PIL Ocaliva | ANO |
RAPIBLOC 20MG/2ML | SmPC Rapibloc | PIL Rapibloc | ANO |
RAPIBLOC 300MG | SmPC Rapibloc 300 | PIL Rapibloc 300 | ANO |
TADALAFIL AOP | SmPC Tadalafil AOP | PIL Tadalafil AOP | ANO |
TETMODIS | SmPC Tetmodis | PIL Tetmodis | ANO |
THROMBOREDUCTIN | SmPC Thromboreductin | PIL Thromboreductin | ANO |
TREPULMIX | SmPC Trepulmix | PIL Trepulmix | NE |
TRESUVI | SmPC Tresuvi | PIL Tresuvi | ANO |
WAKIX | SmPC Wakix | PIL Wakix | ANO |
AOP Health's focus is on integrated therapies for rare diseases and in critical care. The portfolio comprises products in the following therapeutic areas: Hemato-oncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders and Critical Care. AOP Health’s strategic goal is to constantly deliver new treatment options with respect to rare diseases and critical care.